检索

标题
作者
Soluble suppression of tumorigenicity 2 (sST2) as a predictor of adverse outcomes of chronic heart failure
Kravchenko A., Budnevsky A., Chernik T., Tokmachev R.
Results of a 12-month telemonitoring of chronic heart failure patients after hospitalization with its decompensation
Pyrikova N., Mozgunov N., Osipova I.
Clinical observation of a patient with primary hypoparathyroidism, uncontrolled hypocalcemia and heart failure
Katushkina Y., Tatarintseva Z., Kosmacheva E., Petrik G.
New opportunities for chronic heart failure patients’ treatment: focus at dapagliflosin
Malimon V., Kokorin V.
Modern opportunities for treatment of patient having chronic heart failure with low ejection fraction
Roitberg G., Ardashev A., Zhelyakov E., Kondratova N., Merzyavko L., Ponkina N., Slastnikova I., Sokolov D.
Treatment of comorbid patients over 80 years old: focus at arterial hypertension (analysis of real clinical practice)
Safronenko V., Chesnikova A.
Indexes of left ventricle contractive function in persons after acute coronary event, depending on the presence of diabetes mellitus and sodium-glucose transporter inhibitors type 2 use
Nevzorova V., Semenova P., Zakharchuk N., Ivina A.
Gender peculiarities of clinical manifestations in patients with arterial hypertension and chronic heart failure in combination with senile asthenia syndrome
Safronenko V., Chesnikova A.
The effect of meldonium on the heart rate variability in the complex therapy of patients with chronic heart failure and chronic obstructive pulmonary disease
Statsenko M., Turkina S., Lopushkova Y.
Possibilities of early diagnosis of chronic heart failure and chronic kidney disease in patients with type 2 diabetes mellitus at the hospital stage
Demidova T., Izmailova M., Antsiferov M.
Blockade of renin-angiotensin-aldosterone system in patients with chronic heart failure and chronic kidney disease
Shutov A., Efremova E., Serov V.
Use of dapagliflozin in a comorbid patient: new opportunities
Panevin T., Eliseev M., Bobkova A., Dimitreva A., Urumova M.
Life quality and prognosis of patients with adverse post-infarction left ventricle remodeling
Salyamova L., Kvasova O., Babkina I., Rymar V.
Role of visceral obesity in the progression of main arteries rigidity in chronic heart failure patients
Statsenko M., Derevyanchenko M., Fabritskaya S., Ryndina Y., Streltsova A.
Comorbid patient with chronic heart failure: possibilities of sacubitril/valsartan
Larina V.
Risk factors for the development of adverse outcomes in patients with chronic obstructive pulmonary disease
Karoli N., Borodkin A., Rebrov A.
Potentials for the use of diuretic therapy in the clinic of internal diseases
Yevdokimova A., Kovalenko Y., Yevdokimov V., Shuiskaya O.
THORNY PATH TO THE DIAGNOSIS OF «AMYLOIDOSIS OF THE HEART»
Tarasova L., Dubova A., Dimitrieva O., Khripunova O.
The role of cytoprotectors in the treatment of patients with chronic forms of coronary heart disease
Mikhin V., Nikolenko T., Gromnatsky N.
Functional condition of platelets and blood rheology in patients with chronic heart failure with cardiopulmonary pathology
Evdokimov V., Kovalenko E., Evdokimova A., Klevtsova N., Yushchuk E., Tebloev K.
Psycho-emotional disorders in chronic heart failure patients
Shishkova V., Ustarbekova D., Shishkov V., Imamgayazova K., Kapustina L.
Disturbances of water and electrolyte homeostasis as a predictor of an unfavorable long-term prognosis in patients hospitalized for decompensated CHF
Fazulina C., Fomin V., Meshalkina V.
Place of loop diurethics in treatment of chronic heart failure
Tolpygina S.
Community-acquired pneumonia in patients with decompensated chronic heart failure
Simbirtseva A.
Application of Mildronate in patients with comorbidity: focus on cardioneurology
Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S.
BENDOPNEA AND GLOBAL LEFT VENTRICULAR FUNCTION INDEX AS POSSIBLE FACTORS FOR PREDICTION OF MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE
Larina V., Lunev V.
JDP2 - a new promising biological marker in cardiovascular pathology
Alieva A., Reznik E., Teplova N., Totolyan G., Gasanova E., Kalova M., Sabanchieva E., Nikitin I.
Obstructive sleep apnea and chronic heart failure
Bolieva L., Adasheva T., Malyavin A., Bichenova E., Daurova M.
New perspectives and real possibilities in the treatment of patients with heart failure
Shulkina S., Kokorin V.
EPLERENONE IN MYOCARDIAL INFARCTION
Gordeev I., Taratukhin Y., Razumova Y.
The role of ketonemia induced by sodium-glucose cotransporter 2 inhibitors: from the energy exchange to cardioprotection
Salukhov V., Khalimov Y., Cherkashin D., Kadin D.
Hyperammonemia in the practice of a therapist and cardiologist: theoretical and practical significance
Khlynova O., Skachkova V.
Sacubitril/valsartan - novel direction in heart failure treatment
Taratukhin E.
The evaluation of lipid profile in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease
Vatutin N., Smirnova A., Gasendich Y.
Angiotensin II receptor blockers: focus on cardesartan
Cheltsov V., Gushina Y., Illarioniva T., Korovyakova E., Moiseeva A., Pereversev A., Stefanenko Y., Ziryanov S.
EFFECTIVENESS OF BLOCKERS OF THE MINERALOCORTICOID RECEPTORS (SPIRONOLACTONE, EPLERENONE) IN CHRONIC HEART FAILURE
Cheltsov V., Martynov A.
Soluble suppression of tumorigenicity 2 (sST2) in chronic heart failure
Kravchenko A., Chernik T., Tokmachev R.
Review of current opportunities in cardiovascular risks management in patients with type 2 diabetes mellitus
Demidova T., Mkrtamyan A.
Treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: is there a light at the end of the tunnel?
Kokorin V., Boeva O.
TAURIN IN COMPLEX THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE
Teplova N., Abduragimov S., Volov N., Sofrina S., Benevskaya M.
Such different sartans. Place of candesartan
Shaposhnik I.
Antagonists of mineralocorticoid receptors in myocardial infarction: focus on eplerenone
Khokhlov A., Rybachkova Y.
LOOP DIURETIC TORASEMID IN THE TREATMENT OF ARTERIAL HYPERTENSION
GORDEEV I., TARATUKHIN Y., BAIKOVA O.
Relationship of aldosterone and tissue inhibitor of matrix metalloproteinase-1 in the pathogenesis of chronic heart failure with a moderately reduced ejection fraction in patients with diabetes mellitus
Efremova L., Vasilyeva L.
The structure of the prevalence of cardiovascular diseases and chronic kidney disease in patients with type 2 diabetes mellitus in the stationary care
Demidova T., Izmailova M.
Prognostication of the clinical course of heart failure in elderly patients having chronic kidney disease
Larina V., Lunev V., Larin V., Golovko M., Sidorova V.
Modern aspects of diagnosis and treatment of chi heart failure: what’s new?
Shaposhnik I.
Metabolic therapy in chronic heart failure
Cheltsov V., Martynov A., Gushchina Y., Illarionova T., Korovyakova E.
THE ABILITY OF TORASEMIDE FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE
Statsenko M., Turkina S.
The place of bisoprolol cardioselective betaadrenoblocker in treatment of patients with different chronic heart failure phenotypes
Larina V., Larin V.
Torasemide and furosemide: similarities and differences
Cheltsov V.
Impact of physical rehabilitation on the course of chronic heart failure
Budnevsky A., Kravchenko A., Tokmachev R., Chernik T.
Biomarkers in cardiology: microRNA and heart failure
Alieva A., Teplova N., Kislyakov V., Voronkova K., Shnakhova L., Valiev R., Rakhaev A., Elmurzaeva D., Malkarova D., Nikitin I.
Sindecan-1 and cardiovascular diseases
Alieva A., Pinchuk T., Batov M., Voronkova K., Valiev R., Shnakhova L., Kalova M., Rakhaev A., Arakelyan R., Nikitin I.
Endotoxin and endothelial dysfunction in patients with heart failure
Konev Y., Lazebnik L., Levchenko S., Yefremov L.
Place of eplerenone in the therapy of cardiovascular diseases
Tolpygina S.
Biomarkers in cardiology: lipocalin associated with neutrophil gelatinase (NGAL) and cardiovascular diseases
Alieva A., Teplova N., Reznik E., Valiev R., Rakhaev A., Kudaeva M., Akhmatov I., Arakelyan R., Nikitin I.
Features of use of angiotensin receptor blockers in clinical practice (focus on candesartan)
Evdokimova A., Kovalenko Y., Evdokimov V., Tebloev K., Shvetsova I.
Potentials for the additional medical correction cytoprotectors in patients with chronic heart fa and nonalcoholic fatty liver disease
Statsenko M., Turkina S., Shilina N., Kosivtsova M.
ALGORITHM OF DIFFERENTIAL PRESCRIPTION OF CYTOPROTECTORS IN PATIENTS WITH CHRONIC HEART FAILURE AND DISORDERS OF CARBOHYDRATE METABOLISM
Statsenko M., Turkina S.
1 - 60 的 60 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##